Videos de Experimentos Relacionados
Tratamiento con interferón beta para la esclerosis múltiple.
Lancet (London, England)
|February 16, 1999
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Dendritic and parallel processing of visual threats in the retina control defensive responses.
Science advances·2020
Same author
Development and Characterization of 12 Novel Polymorphic Microsatellite Loci for the Mammal Chewing Louse Geomydoecus aurei (Insecta: Phthiraptera) and a Comparison of Next-Generation Sequencing Approaches for Use in Parasitology.
The Journal of parasitology·2017
Same author
Patterns of cryptic host specificity in duck lice based on molecular data.
Medical and veterinary entomology·2016
Same author
Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowl.
Molecular ecology·2009
Same author
Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)·2007
Same author
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England)·2006
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026